In their Practice article in CMAJ,1 Moayedi and colleagues illustrate how challenging it can be to rule in or out acute heart failure in a patient with undifferentiated dyspnea. The authors suggested testing brain natriuretic peptide (BNP) or N-terminal pro BNP (NT-proBNP) level, listing the respective test result thresholds above which heart failure is “likely.” But how is a clinician to interpret these dichotomous test results at the bedside — Is a slightly positive result less likely to be correct than a moderately elevated result, versus a markedly elevated one? How much does the clinician’s gestalt factor into the final decision-making?
With these issues in mind, we retrospectively studied this patient population in the emergency department setting and derived a diagnostic mathematical model using only the patient’s age, the clinician’s pretest probability and the absolute value of NT-proBNP.2 We then validated it prospectively in an international randomized controlled trial.3 This clinical prediction tool is available to anyone on a universally accessible website or application (available at www.mdcalc.com/steinhart-model-acute-heart-failure-ahf-undifferentiated-dyspnea).
In creating this tool, my colleagues and I hope to reduce the guesswork when trying to assimilate test results for BNP in this challenging patient population.
Footnotes
Competing interests: None declared.